Trials / Completed
CompletedNCT03428867
Register Study of the Neoadjuvanten Treatment by Patients With Rectumcarcinoma
Phase II Studie Zur Neoadjuvanten Trimodalen Hyperthermen Radiochemotherapie Des Tief Sitzenden Rektumskarzinoms im Stadium UICC II + III
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 78 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
goal of this study is to check the effecivity, feasibility and toxicity of the chemoradiotherapy and hyperthermia
Detailed description
Radiation: 5x1,8Gy until 50,4 Gy Hyperthermia: 2x/week Chemotherapy: neoadjuvant= day 1-5 and day 29-33 5FU 1000mg/m2 adjuvant = 4 Cycles 5FU 500mg/m2 all 4 weeks
Conditions
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-31
- First posted
- 2018-02-12
- Last updated
- 2018-02-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03428867. Inclusion in this directory is not an endorsement.